CCR9 and neoplasm: The results showed that LY294002 could significantly inhibit the growth of SACC-LM cells induced by CCL25, but the number of dead tumor cells did not increase significantly when CCR9 inhibitor (VCN) was added into the tumor cells with the present of LY294002.